Sumatriptan Tablets

Type of Posting: 
Revision Bulletin
Posting Date: 
25–Feb–2011
Official Date: 
01–Mar–2011
Expert Committee: 
Monographs—Small Molecules 4
Reason for Revision: 
Compliance

In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 4 Expert Committee has revised the Sumatriptan Tablets monograph. The purpose for the revision is to:

  • Modify the Identification by IR by deleting the wavenumber 767 cm-1 as this also corresponds to an excipient absorption band; and
  • Add a Dissolution Test 2 for a generic product recently approved by FDA

The Sumatriptan Tablets Revision Bulletin supersedes the currently official Sumatriptan Tablets monograph. The Revision Bulletin will be incorporated in the Second Supplement of USP 34–NF 29.

Should you have any questions about the Identification revision, please contact R. Ravichandran Ph.D. (301-816-8330 or rr@usp.org). For questions about Dissolution revision, please contact Margareth Marques, Ph.D. (301-816-8106 or mrm@usp.org).